Convalescent Plasma Treatment for COVID-19: FDA Approval for Emergency Use Authorization
The efforts of the researchers across the world to combat the new corona virus are invaluable. Various research organizations and medical centers coming-up with cutting-edge techniques right from the precautionary advisory to the high-end treatment. Treatment accompanied with re-purposing of the drugs through discovering the vaccines is on the way.
It was learnt from some studies that, Convalescent Plasma Treatment in emergency do positively indicated for treating the novel corona virus. Experts have expressed the optimism towards this as well.
On August 23, 2020 the US Food and Drug Administration issued an emergency use authorization for Investigational convalescent plasma for treatment of COVID-19 hospitalized patients. This decision was made according to the in-detail review of the data generated out of the convalescent plasma therapy.
“I am committed to releasing safe and potentially helpful treatments for COVID-19 as quickly as possible in order to save lives. We’re encouraged by the early promising data that we’ve seen about convalescent plasma. The data from studies conducted this year shows that plasma from patients who’ve recovered from COVID-19 has the potential to help treat those who are suffering from the effects of getting this terrible virus,”. “At the same time, we will continue to work with researchers to continue randomized clinical trials to study the safety and effectiveness of convalescent plasma in treating patients infected with the novel coronavirus.” – Statement by Stephen M. Hahn, M.D., FDA Commissioner (source: https://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-convalescent-plasma-potential-promising-covid-19-treatment)
Convalescent plasma is derived from the blood of individuals who have recovered from the corona virus and has been used to treat other viruses.
